Government Initiatives will Unlock Enormous Potential Opportunities for the Russian Pharmaceutical Market
With total revenues of $15.3 billion in 2009, the Russian pharmaceutical market is one of the largest in the world. The market is anticipated to remain on a path of dynamic growth from 2010 to 2016 mainly due to multiple initiatives of the Russian Government. However, in the short term, the process of implementing legislative changes could slightly restrain the market's development.
Read more ...
Nutrition deemed a growing challenge for health in the EU and beyond
Over half the EU adult population is now overweight or obese according to the "Health at a Glance: Europe 2010" report published by the European Commission and the OECD. The rate of obesity has more than doubled over the past 20 years in most EU Member States. This has considerable implications on health, health systems and on the wider economy. This is one of the many findings in a report which provides useful insight into the current situation of health in the EU.
Read more ...
New technique to speed up drug development
Scientists working at the European Molecular Biology Laboratory (EMBL) in Grenoble, France have developed a new technique that enables them to introduce up to 15 fluorescent markers to a mammalian cell in one go. They say their findings could help speed up drug development and screening.
Read more ...
Reasons Why mHealth Apps Matters for Pharma
The potential of mHealth solutions has been discussed for many years, but only recently, with the advent of the new smartphone application based mHealth model, have pharmaceutical companies begun to realize how mobile services might be instrumental in the development of exciting innovations in their own businesses.
Read more ...
Europeans are Interested in Online Patient Education Programs
Half of Europeans using the Internet for health information are interested in online patient education programs from pharmaceutical companies, although just a small fraction are currently using these types of programs, according to Manhattan Research's Cybercitizen Health® Europe v10.0 research. The survey explored the digital media and online health behaviors of 3,000 online adults in France, Germany, Italy, Spain, and the United Kingdom.
Read more ...
Philippe Tsvetkov et al. present new perspective on Alzheimer's disease drug development
A team of researchers (Philippe Tsvetkov et al.) from Engelhardt Institute of Molecular Biology (Moscow, Russia) have shed light on molecular mechanisms of Alzheimer's disease with perspective on development of novel drug therapies. The study, published in Biophysical Journal, provides insights into molecular mechanisms of Zinc-induced aggregation of amyloid-β peptide.
Read more ...
Multidrug resistant bacteria remain a public health issue in Europe
On the occasion of the European Antibiotic Awareness Day, ECDC is releasing new European-wide surveillance data on antibiotic resistance from the European Antimicrobial Resistance Surveillance Network (EARS-Net). With annually up to 400,000 patients [1]reported to suffer from infections resistant to multiple antibiotics, the data show that antibiotic resistance remains a public health problem across the European Union.
Read more ...